The Center is proud to be able to receive one of the first Sonablate® HIFU Systems in the country and to partner with Dr. Lazar and HIFU Prostate Services to offer our patients a viable option for prostate cancer.
San Francisco, CA (PRWEB) November 19, 2015
HIFU Prostate Services, LLC, a leading provider of minimally- invasive prostate cancer treatment, using High Intensity Focused Ultrasound (HIFU), announced that physician partner and Medical Director, Michael J. Lazar, MD will treat the first prostate cancer patient in California with minimally invasive HIFU on November 18, in San Francisco at the San Francisco Surgery Center (SFSC). This will be the second patient ever treated in the country using Sonablate HIFU technology.
HIFU Prostate Services has partnered with Lazar and SFSC to establish a HIFU Center of Excellence where patients can receive the recently FDA-cleared Sonablate HIFU treatment. SFSC is located in downtown San Francisco, near Union Square, which offers patients a state-of-the-art facility in downtown that is convenient to hotels and the airport for men who will be traveling from around the country for this non-invasive treatment.
Lazar, who also serves as Medical Director of HIFU Prostate Services, has been working with HIFU since 2007, and was one of three physicians who proctored cases during clinical trials. Lazar will offer HIFU treatment to qualified patients and also provide medical guidance and serve as a proctor to physicians that are being trained on the Sonablate® HIFU system in San Francisco and surgery centers around the country.
Kevin Wienke, Administrator of the San Francisco Surgery Center states, “The Center is proud to be able to receive one of the first Sonablate® HIFU Systems in the country and to partner with Dr. Lazar and HIFU Prostate Services to offer our patients a viable option for prostate cancer.”
John W. Linn, chief executive officer of HIFU Prostate Services said, “The Sonablate® is the first device to receive regulatory authorization from the FDA for the ablation of prostate tissue. HIFU has been available in other countries for more than 10 years, but we are proud to be the first to make this game-changing technology available in the United States”.
Since 2004, approximately 4,000 U.S. men have been treated outside the U.S. where this technology is approved in over 30 countries. HIFU offers an effective treatment for localized prostate cancer with significantly less risk of common side effects, such as impotence and incontinence, which are typically reported with surgery and radiation.
Ken Hicks, a patient of Dr. Lazar’s who received HIFU treatment in 2007 in Puerto Vallarta, Mexico says, “Finally men in the U.S. can receive this innovative, minimally invasive therapy for their prostate cancers without traveling internationally. I still can’t believe I was eating dinner on the beach just hours after my HIFU procedure and I am doing great after 7 years. I highly recommend Dr. Lazar and HIFU to anyone who is eligible for this incredible procedure.”
Dr. Lazar has been working with HIFU patients since 2007. He is currently the Medical Director of HIFU Prostate Services (HPS) and clinical partner with HPS and SFSC with the HIFU program. He has been certified by the American Board of Urology four times and has practiced in Santa Rosa, Calif. since 1983. He is chairman of the Board of Redwood Health Services, Inc. providing insurance products for employee groups. Lazar is also CEO and managing director of Santa Rosa Surgical Management Company, LLC that manages the ambulatory surgery center at Santa Rosa Memorial Hospital. Lazar received his urology training at Louisiana State University in New Orleans, La. and is a graduate of University of Arkansas Medical School.
For more information on Dr. Lazar, visit http://www.californiahifu.com
About HIFU Prostate Services, LLC
HIFU Prostate Services (HPS) was founded in 2015 to provide men access to a less invasive treatment option for prostate disease focused on preserving quality of life. The mission of HPS is to partner with physicians to deliver the highest quality of care, support and technology to the patient and to the urology community for the treatment of localized prostate cancer using high intensity focused ultrasound (HIFU). HPS is lead by a seasoned management team with over 50 years of experience in the healthcare industry and over 30 years focused on HIFU technologies The company is headquartered in Charlotte, NC.
For additional information, visit http://www.hifuprostateservices.com